NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

NOVO.B.DK

227.2

-5.2%↓

GMAB.DK

1,680

-0.77%↓

HLUNB.DK

38.56

-0.36%↓

ZEAL.DK

286.2

-1.48%↓

AMBUB.DK

67.7

-1.81%↓

Search

Coloplast A-S (Class B)

Suletud

430 -1.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

428.2

Max

439.7

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

24.382

57.05

Aktsiakasum

6.32

Dividenditootlus

5.47

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

5.47%

2.52%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-21B

97B

Eelmine avamishind

431.26

Eelmine sulgemishind

430

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. märts 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26. märts 2026, 23:36 UTC

Market Talk
Uudisväärsed sündmused

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26. märts 2026, 23:35 UTC

Omandamised, ülevõtmised, äriostud

Pernod Ricard: Confirms Discussions With Brown-Forman

26. märts 2026, 23:29 UTC

Tulu

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26. märts 2026, 23:28 UTC

Tulu

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26. märts 2026, 23:27 UTC

Tulu

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26. märts 2026, 23:27 UTC

Tulu

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26. märts 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26. märts 2026, 23:04 UTC

Omandamised, ülevõtmised, äriostud

Pernod in Deal Talks With Brown-Forman -- WSJ

26. märts 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26. märts 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26. märts 2026, 22:26 UTC

Tulu

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26. märts 2026, 22:08 UTC

Tulu

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26. märts 2026, 22:08 UTC

Tulu

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26. märts 2026, 22:08 UTC

Tulu

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26. märts 2026, 22:07 UTC

Market Talk
Uudisväärsed sündmused

Global Energy Roundup: Market Talk

26. märts 2026, 22:07 UTC

Market Talk
Uudisväärsed sündmused

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26. märts 2026, 22:00 UTC

Tulu

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26. märts 2026, 21:39 UTC

Omandamised, ülevõtmised, äriostud

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26. märts 2026, 21:38 UTC

Omandamised, ülevõtmised, äriostud

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat